Total Payments
$4,089
2024 Payments
$3,313
Companies
33
Transactions
114
Medicare Patients
1,152
Medicare Billing
$39,940
Payment Breakdown by Category
Food & Beverage$2,852 (69.7%)
Travel$1,169 (28.6%)
Education$68.00 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,852 | 111 | 69.7% |
| Travel and Lodging | $1,169 | 2 | 28.6% |
| Education | $68.00 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Axonics, Inc. | $1,705 | 9 | $0 (2024) |
| PFIZER INC. | $401.86 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $274.11 | 10 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $190.04 | 6 | $0 (2024) |
| Boston Scientific Corporation | $174.32 | 8 | $0 (2024) |
| Tempus AI, Inc | $167.45 | 3 | $0 (2024) |
| UROGEN PHARMA, INC. | $166.32 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $150.89 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $105.22 | 5 | $0 (2024) |
| ABBVIE INC. | $104.89 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,313 | 82 | Axonics, Inc. ($1,620) |
| 2023 | $527.49 | 21 | Myriad Genetic Laboratories, Inc. ($122.42) |
| 2022 | $131.92 | 8 | Novo Nordisk Inc ($34.92) |
| 2021 | $117.19 | 3 | Axonics, Inc. ($84.39) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: Prostate cancer | ||||||
| 12/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.49 | General |
| 11/05/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Oncology | ||||||
| 10/25/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Oncology | ||||||
| 10/01/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $120.47 | General |
| Category: NONE | ||||||
| 09/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 473 | 501 | $51,436 | $14,842 |
| 2022 | 12 | 579 | 612 | $57,311 | $19,381 |
| 2021 | 5 | 100 | 102 | $14,084 | $5,717 |
Total Patients
1,152
Total Services
1,215
Medicare Billing
$39,940
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 108 | $24,010 | $7,014 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 145 | $22,606 | $5,974 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 71 | $732.00 | $596.40 | 81.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 43 | 43 | $792.00 | $356.47 | 45.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 38 | 39 | $614.00 | $296.79 | 48.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 12 | 12 | $410.00 | $197.52 | 48.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 15 | 18 | $1,350 | $135.18 | 10.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $472.00 | $133.80 | 28.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 28 | $336.00 | $95.48 | 28.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 19 | $114.00 | $41.80 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 143 | $22,880 | $7,366 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 97 | $21,961 | $7,325 | 33.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 13 | $6,370 | $2,281 | 35.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 65 | 67 | $1,474 | $557.59 | 37.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 67 | 70 | $1,260 | $534.86 | 42.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 24 | $816.00 | $389.94 | 47.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 89 | 92 | $909.00 | $271.62 | 29.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 12 | 12 | $480.00 | $198.20 | 41.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 11 | 11 | $385.00 | $145.30 | 37.7% |
| 84460 | Liver enzyme (sgpt), level | Office | 2022 | 22 | 22 | $264.00 | $114.54 | 43.4% |
| 84450 | Liver enzyme (sgot), level | Office | 2022 | 22 | 22 | $264.00 | $112.06 | 42.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 38 | 39 | $248.00 | $84.42 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 42 | $5,475 | $2,455 | 44.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 23 | 23 | $4,003 | $1,180 | 29.5% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2021 | 11 | 11 | $1,676 | $1,054 | 62.9% |
About Laura Mathis
Laura Mathis is a Family healthcare provider based in Sevierville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2015. The National Provider Identifier (NPI) number assigned to this provider is 1841666583.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Laura Mathis has received a total of $4,089 in payments from pharmaceutical and medical device companies, with $3,313 received in 2024. These payments were reported across 114 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,852).
As a Medicare-enrolled provider, Mathis has provided services to 1,152 Medicare beneficiaries, totaling 1,215 services with total Medicare billing of $39,940. Data is available for 3 years (2021–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Sevierville, TN
- Active Since 08/17/2015
- Last Updated 08/10/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1841666583
Products in Payments
- Axonics (Device) $1,620
- XTANDI (Drug) $384.87
- ERLEADA (Drug) $260.75
- PROLARIS (Device) $190.04
- XT CDX (Device) $167.45
- JELMYTO (Drug) $166.32
- Nubeqa (Drug) $105.22
- BOTOX (Biological) $104.89
- Axonics r-SNM System (Device) $84.39
- POSLUMA (Drug) $66.44
- Myrbetriq (Drug) $61.01
- ADSTILADRIN (Biological) $45.36
- Rybelsus (Drug) $40.56
- CYSVIEW (Drug) $39.50
- PERCLOT (Device) $29.80
- Axumin (Drug) $27.90
- Lumenis Pulse 120H (Device) $24.91
- Trelstar (Drug) $24.69
- PYLARIFY (Drug) $22.25
- Xtandi (Drug) $21.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sevierville
Melissa Graves, Fnp, FNP
Family — Payments: $9,457
Family $9,457
Jennifer Marsh, Apn, Fnp-C, APN, FNP-C
Family — Payments: $4,893
Family $4,893
Leigh Jones, Fnp, FNP
Family — Payments: $3,430
Family $3,430
Ms. Jennifer Lane, Fnp-C, FNP-C
Family — Payments: $3,395
Family $3,395
Lori Shumaker, Fnp, FNP
Family — Payments: $3,195
Family $3,195
Melissa Blair, Fnp-Bc, FNP-BC
Family — Payments: $2,656
Family $2,656